| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner
6 companies
Polaris Venture Management Co. V, L.l.c. is a 10% Owner at CDLX, with reported holdings spanning 6 companies. Recent filings cover 12 purchases and 64 sales. Those positions are worth an estimated $1.3M at current prices.
Polaris Venture Management Co. V, L.l.c.'s largest disclosed position is in CDLX as 10% Owner, worth about $585K. The recent filings there lean toward selling, a net 494,011 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 5, 2020 | LYRA Lyra Therapeutics, Inc. | 10% Owner | Sell | 9,674 | $16.00 | $154,784.00 | -58.5% | |
| May 5, 2020 | LYRA Lyra Therapeutics, Inc. | 10% Owner | Buy | 62,500 | $16.00 | $1,000,000.00 | -113.2% | |
| Jul 17, 2019 | CDLX Cardlytics, Inc. | 10% Owner | Sell | 68,727 | $27.66 | $1,900,767.37 | -76.3% | |
| Jun 7, 2019 | CDLX Cardlytics, Inc. | 10% Owner | Sell | 100,000 | $25.62 | $2,562,120.00 | -82.0% | |
| Jun 6, 2019 | CDLX Cardlytics, Inc. | 10% Owner | Sell | 75,284 | $24.10 | $1,814,073.25 | -76.6% | |
| May 28, 2019 | CDLX Cardlytics, Inc. | 10% Owner | Sell | 100,000 | $23.04 | $2,303,810.00 | -80.9% | |
| Sep 13, 2018 | CDLX Cardlytics, Inc. | Director, 10% Owner | Sell | 150,000 | $25.04 | $3,756,280.86 | -85.9% | |
| Nov 20, 2017 | XFOR X4 Pharmaceuticals, Inc | 10% Owner | Buy | 500,000 | $10.00 | $5,000,000.00 | -103.7% | |
| Jun 27, 2016 | RNAC Cartesian Therapeutics, Inc. | 10% Owner | Buy | 150,000 | $14.00 | $2,100,000.00 | +8.9% | |
| Feb 2, 2015 | OCUL Ocular Therapeutix, Inc | 10% Owner | Sell | 500,000 | $29.50 | $14,750,000.00 | -96.2% |